We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.

Welcome to Pump.fun!
Pump lets anyone create coins, giving everyone equal access to buy and sell from the start. Prices can move quickly, so trade carefully.
By clicking this button, you agree to the Terms and Conditions, Privacy Policy, and certify that you are over 18 years old.
| $30.14% | |
| $10.07% | |
| $0.460.03% | |
| $0.350.02% | |
| $0.240.01% | |
| $0.160.01% | |
| $0.100.01% | |
| $0.050.00% | |
| $0.010.00% | |
| $0.000.00% | |
| $0.000.00% | |
| $0.000.00% | |
| $0.000.00% |
iPSCs: Cutting-edge regenerative medicine making human immortality possible! Recently, a research team from Osaka University Hospital successfully conducted the world's first clinical trial using induced pluripotent stem cells (iPSCs) to treat severe corneal injuries. Japan’s Heartseed Institute has taken it a step further by utilizing iPSC cell transplantation to regenerate a new heart directly within the body. Heartseed's groundbreaking innovations and potential have earned it numerous accolades, including the Minister of State for Science and Technology Policy Award at the Japan Venture Awards 2021. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01764-1/fulltext https://heartseed.jp/